Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association
CHICAGO, June 21, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…
GTreasury Launches GSmart AI, Setting the Standard for Secure, Adaptable, and Agentic AI in Treasury Operations
CHICAGO, June 18, 2025 (GLOBE NEWSWIRE) -- GTreasury, the global leader in…
LANZAJET EXPANDS PARTNERSHIP WITH MICROSOFT TO STRENGTHEN THE COMPANY’S GLOBAL GROWTH
This agreement deepens multi-level collaboration with Microsoft across climate investment, renewable fuel…
New Survey Finds Younger Adults, More Women Seeking Treatment for Hair Loss
Manageable number of monthly hair restoration surgeries illustrates ISHRS members'Â hands-on, expert approach…
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit United for Progress: A New Chapter in Sarcoidosis
CHICAGO, June 04, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research…
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a…